“STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS”. International Research Journal of Pharmacy, vol. 9, no. 8, Aug. 2018, pp. 125-8, https://doi.org/10.56802/gzfvmr94.